The Enterprise Value as of December 2025 (TTM) for Laurus Labs Limited (LAURUSLABS.BO) is 575.43B

According to Laurus Labs Limited’s latest financial reports and current stock price. The company's current Enterprise Value is 575.43B. This represents a change of 49.32% compared to the average of 385.37B of the last 4 quarters.

Laurus Labs Limited (LAURUSLABS.BO) Historical Enterprise Value (quarterly & annually)

How has LAURUSLABS.BO Enterprise Value performed in the past?

The mean historical Enterprise Value of Laurus Labs Limited over the last ten years is 159.02B. The current 575.43B Enterprise Value has changed 36.08% with respect to the historical average. Over the past ten years (40 quarters), LAURUSLABS.BO's Enterprise Value was at its highest in in the September 2025 quarter at 475.91B. The Enterprise Value was at its lowest in in the January 2016 quarter at 0.

Laurus Labs Limited (LAURUSLABS.BO) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Laurus Labs Limited Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Laurus Labs Limited (LAURUSLABS.BO) Average Enterprise Value

How has LAURUSLABS.BO Enterprise Value performed in the past?

The current Enterprise Value of Laurus Labs Limited (LAURUSLABS.BO) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Laurus Labs Limited (LAURUSLABS.BO) Enterprise Value vs. Peers

How is LAURUSLABS.BO’s Enterprise Value compared to its peers?

Laurus Labs Limited’s Enterprise Value is greater than Glenmark Pharmaceuticals Limited (555.43B), greater than Glenmark Pharmaceuticals Limited (555.43B), less than Aurobindo Pharma Limited (696.22B), less than Biocon Limited (646.83B), less than Alkem Laboratories Limited (699.89B), less than Biocon Limited (646.83B), less than Alkem Laboratories Limited (699.89B), greater than GlaxoSmithKline Pharmaceuticals Limited (424.12B), less than Aurobindo Pharma Limited (696.22B), greater than GlaxoSmithKline Pharmaceuticals Limited (424.12B),

Build a custom stock screener for Laurus Labs Limited (LAURUSLABS.BO) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Laurus Labs Limited using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Laurus Labs Limited (LAURUSLABS.BO) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Laurus Labs Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.